Calcitonin-salmon: profile and news
Nastech's Facility Approved for Commercial Manufacturing of ... Feb 28, 2006
Successful completion of this PAI enables Nastech to manufacture calcitonin-salmon nasal spray for commercial use upon FDA approval of the Company's ANDA ... - PR Newswire (press release),
FDA approves Bothell facility for making osteoporosis spray Feb 28, 2006
...announced Tuesday the successful completion of the FDA's pre-approval inspection of its Bothell facility for the manufacture of a calcitonin-salmon nasal spray ... - Puget Sound Business Journal,
Nastech site OK'd for osteoporosis spray Feb 28, 2006
The company said the Food and Drug Administration accepted its filing in February 2004 seeking approval of the generic calcitonin-salmon nasal spray. ... - United Press International
Business briefs Mar 1, 2006
Possible approval of Nastech's generic calcitonin-salmon drug has been slowed by a petition filed with the FDA that seeks to delay production of generics. ... - The Herald,
Hurdles block generic drugs Feb 13, 2006
Nastech, which focuses on developing new and reformulated nasal drugs, took a different approach with calcitonin-salmon, Miacalcin's generic name. ... - Seattle Times,
Study shows calcitonin-salmon nasal spray helps prevent new spinal ... Nov 30, 2005
14, 1998 -- A recently completed study shows that calcitonin-salmon nasal spray reduced by 36 percent the incidence of new spinal fractures in postmenopausal ... - uwnews.org,
Upsher-Smith launches NEW Fortical(R) Nasal Spray for ... Aug 16, 2005
...announces the launch of new Fortical(R) calcitonin- salmon (rDNA origin) Nasal Spray, an effective treatment option for postmenopausal osteoporosis in women ... - Business Wire (press release),
FDA Approvals: Fortical, Actonel With Calcium, VAQTA Aug 18, 2005
18, 2005 — The US Food and Drug Administration (FDA) has approved calcitonin-salmon [rDNA origin] nasal spray for the treatment of osteoporosis in women more ... - Medscape (subscription)
Nastech Brings In $23M To Support PTH Nasal Program Aug 25, 2005
Aside from PTH1-34, Nastech has one other product to treat osteoporosis - calcitonin-salmon nasal spray, a generic partnered with Par Pharmaceutical Inc., of ... - BioWorld Online (subscription),
FDA Approves Fortical, Unigene's Nasal Calcitonin Product for ... Aug 15, 2005
...(OTCBB:UGNE) has received approval from the US Food and Drug Administration ("FDA") for Fortical(R) calcitonin-salmon (rDNA origin) Nasal Spray, its patented ... - PharmaLive.com (press release),
FDA Approves Fortical, Unigene's Nasal Calcitonin Product for ... Aug 15, 2005
Unigene Laboratories, Inc. (OTCBB:UGNE) has received approval from the US Food and Drug Administration ("FDA") for Fortical(R) calcitonin-salmon (rDNA origin ... - Genetic Engineering News,
New to Market Aug 21, 2005
...osteoporosis. The new Fortical calcitonin-salmon (rDNA origin) nasal spray is being shipped to retail and wholesale outlets. The ... - Minneapolis Star Tribune (subscription),
Upsher-Smith Laboratories and Unigene Laboratories Clarify Upsher ... Jul 18, 2005
...but clarified that neither company has received any communication of a decision by the FDA regarding the approval of Fortical(R) calcitonin-salmon (rDNA origin ... - Business Wire (press release)
Upsher-Smith Laboratories Disappointed in FDA's Decision to Delay ... Jul 18, 2005
Inc., a Minnesota-based pharmaceutical company, expressed disappointment today the FDA's decision to delay approval of Fortical® calcitonin-salmon (rDNA origin ... - Yahoo News (press release)
